Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.88 - $1.73 $6,600 - $12,975
-7,500 Reduced 42.86%
10,000 $9,000
Q3 2021

Nov 15, 2021

SELL
$2.62 - $3.45 $11,790 - $15,525
-4,500 Reduced 20.45%
17,500 $48,000
Q1 2021

May 17, 2021

BUY
$1.89 - $2.96 $13,230 - $20,720
7,000 Added 46.67%
22,000 $47,000
Q4 2020

Feb 12, 2021

BUY
$0.65 - $1.94 $9,750 - $29,100
15,000 New
15,000 $29,000

Others Institutions Holding VTGN

About VistaGen Therapeutics, Inc.


  • Ticker VTGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 206,836,000
  • Market Cap $730M
  • Description
  • VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...
More about VTGN
Track This Portfolio

Track Integrated Advisors Network LLC Portfolio

Follow Integrated Advisors Network LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Advisors Network LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Advisors Network LLC with notifications on news.